Gene Engineered Subunit Vaccine Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Engineered Subunit Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Therapeutic Gene Engineered Subunit Vaccine
1.2.3 Preventative Gene Engineered Subunit Vaccine
1.3 Market by Application
1.3.1 Global Gene Engineered Subunit Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human Use
1.3.3 Veterinary Use
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Engineered Subunit Vaccine Market Perspective (2017-2028)
2.2 Gene Engineered Subunit Vaccine Growth Trends by Region
2.2.1 Gene Engineered Subunit Vaccine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gene Engineered Subunit Vaccine Historic Market Size by Region (2017-2022)
2.2.3 Gene Engineered Subunit Vaccine Forecasted Market Size by Region (2023-2028)
2.3 Gene Engineered Subunit Vaccine Market Dynamics
2.3.1 Gene Engineered Subunit Vaccine Industry Trends
2.3.2 Gene Engineered Subunit Vaccine Market Drivers
2.3.3 Gene Engineered Subunit Vaccine Market Challenges
2.3.4 Gene Engineered Subunit Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Engineered Subunit Vaccine Players by Revenue
3.1.1 Global Top Gene Engineered Subunit Vaccine Players by Revenue (2017-2022)
3.1.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Players (2017-2022)
3.2 Global Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Engineered Subunit Vaccine Revenue
3.4 Global Gene Engineered Subunit Vaccine Market Concentration Ratio
3.4.1 Global Gene Engineered Subunit Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Engineered Subunit Vaccine Revenue in 2021
3.5 Gene Engineered Subunit Vaccine Key Players Head office and Area Served
3.6 Key Players Gene Engineered Subunit Vaccine Product Solution and Service
3.7 Date of Enter into Gene Engineered Subunit Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Engineered Subunit Vaccine Breakdown Data by Type
4.1 Global Gene Engineered Subunit Vaccine Historic Market Size by Type (2017-2022)
4.2 Global Gene Engineered Subunit Vaccine Forecasted Market Size by Type (2023-2028)
5 Gene Engineered Subunit Vaccine Breakdown Data by Application
5.1 Global Gene Engineered Subunit Vaccine Historic Market Size by Application (2017-2022)
5.2 Global Gene Engineered Subunit Vaccine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gene Engineered Subunit Vaccine Market Size (2017-2028)
6.2 North America Gene Engineered Subunit Vaccine Market Size by Type
6.2.1 North America Gene Engineered Subunit Vaccine Market Size by Type (2017-2022)
6.2.2 North America Gene Engineered Subunit Vaccine Market Size by Type (2023-2028)
6.2.3 North America Gene Engineered Subunit Vaccine Market Share by Type (2017-2028)
6.3 North America Gene Engineered Subunit Vaccine Market Size by Application
6.3.1 North America Gene Engineered Subunit Vaccine Market Size by Application (2017-2022)
6.3.2 North America Gene Engineered Subunit Vaccine Market Size by Application (2023-2028)
6.3.3 North America Gene Engineered Subunit Vaccine Market Share by Application (2017-2028)
6.4 North America Gene Engineered Subunit Vaccine Market Size by Country
6.4.1 North America Gene Engineered Subunit Vaccine Market Size by Country (2017-2022)
6.4.2 North America Gene Engineered Subunit Vaccine Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Gene Engineered Subunit Vaccine Market Size (2017-2028)
7.2 Europe Gene Engineered Subunit Vaccine Market Size by Type
7.2.1 Europe Gene Engineered Subunit Vaccine Market Size by Type (2017-2022)
7.2.2 Europe Gene Engineered Subunit Vaccine Market Size by Type (2023-2028)
7.2.3 Europe Gene Engineered Subunit Vaccine Market Share by Type (2017-2028)
7.3 Europe Gene Engineered Subunit Vaccine Market Size by Application
7.3.1 Europe Gene Engineered Subunit Vaccine Market Size by Application (2017-2022)
7.3.2 Europe Gene Engineered Subunit Vaccine Market Size by Application (2023-2028)
7.3.3 Europe Gene Engineered Subunit Vaccine Market Share by Application (2017-2028)
7.4 Europe Gene Engineered Subunit Vaccine Market Size by Country
7.4.1 Europe Gene Engineered Subunit Vaccine Market Size by Country (2017-2022)
7.4.2 Europe Gene Engineered Subunit Vaccine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Engineered Subunit Vaccine Market Size (2017-2028)
8.2 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type
8.2.1 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Gene Engineered Subunit Vaccine Market Share by Type (2017-2028)
8.3 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application
8.3.1 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Gene Engineered Subunit Vaccine Market Share by Application (2017-2028)
8.4 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Region
8.4.1 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Engineered Subunit Vaccine Market Size (2017-2028)
9.2 Latin America Gene Engineered Subunit Vaccine Market Size by Type
9.2.1 Latin America Gene Engineered Subunit Vaccine Market Size by Type (2017-2022)
9.2.2 Latin America Gene Engineered Subunit Vaccine Market Size by Type (2023-2028)
9.2.3 Latin America Gene Engineered Subunit Vaccine Market Share by Type (2017-2028)
9.3 Latin America Gene Engineered Subunit Vaccine Market Size by Application
9.3.1 Latin America Gene Engineered Subunit Vaccine Market Size by Application (2017-2022)
9.3.2 Latin America Gene Engineered Subunit Vaccine Market Size by Application (2023-2028)
9.3.3 Latin America Gene Engineered Subunit Vaccine Market Share by Application (2017-2028)
9.4 Latin America Gene Engineered Subunit Vaccine Market Size by Country
9.4.1 Latin America Gene Engineered Subunit Vaccine Market Size by Country (2017-2022)
9.4.2 Latin America Gene Engineered Subunit Vaccine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Engineered Subunit Vaccine Market Size (2017-2028)
10.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type
10.2.1 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Gene Engineered Subunit Vaccine Market Share by Type (2017-2028)
10.3 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application
10.3.1 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Gene Engineered Subunit Vaccine Market Share by Application (2017-2028)
10.4 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Country
10.4.1 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Gene Engineered Subunit Vaccine Introduction
11.1.4 Merck Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Gene Engineered Subunit Vaccine Introduction
11.2.4 GSK Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.2.5 GSK Recent Developments
11.3 Tiantan
11.3.1 Tiantan Company Details
11.3.2 Tiantan Business Overview
11.3.3 Tiantan Gene Engineered Subunit Vaccine Introduction
11.3.4 Tiantan Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.3.5 Tiantan Recent Developments
11.4 Pulike
11.4.1 Pulike Company Details
11.4.2 Pulike Business Overview
11.4.3 Pulike Gene Engineered Subunit Vaccine Introduction
11.4.4 Pulike Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.4.5 Pulike Recent Developments
11.5 Greffex
11.5.1 Greffex Company Details
11.5.2 Greffex Business Overview
11.5.3 Greffex Gene Engineered Subunit Vaccine Introduction
11.5.4 Greffex Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.5.5 Greffex Recent Developments
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Business Overview
11.6.3 CureVac Gene Engineered Subunit Vaccine Introduction
11.6.4 CureVac Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.6.5 CureVac Recent Developments
11.7 Yebio
11.7.1 Yebio Company Details
11.7.2 Yebio Business Overview
11.7.3 Yebio Gene Engineered Subunit Vaccine Introduction
11.7.4 Yebio Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.7.5 Yebio Recent Developments
11.8 Sanofi Pasteur SA
11.8.1 Sanofi Pasteur SA Company Details
11.8.2 Sanofi Pasteur SA Business Overview
11.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Introduction
11.8.4 Sanofi Pasteur SA Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.8.5 Sanofi Pasteur SA Recent Developments
11.9 Virbac
11.9.1 Virbac Company Details
11.9.2 Virbac Business Overview
11.9.3 Virbac Gene Engineered Subunit Vaccine Introduction
11.9.4 Virbac Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.9.5 Virbac Recent Developments
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Details
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Introduction
11.10.4 Pfizer Inc. Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.10.5 Pfizer Inc. Recent Developments
11.11 Walvax Biotechnology
11.11.1 Walvax Biotechnology Company Details
11.11.2 Walvax Biotechnology Business Overview
11.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Introduction
11.11.4 Walvax Biotechnology Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.11.5 Walvax Biotechnology Recent Developments
11.12 Kontec
11.12.1 Kontec Company Details
11.12.2 Kontec Business Overview
11.12.3 Kontec Gene Engineered Subunit Vaccine Introduction
11.12.4 Kontec Revenue in Gene Engineered Subunit Vaccine Business (2017-2022)
11.12.5 Kontec Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Engineered Subunit Vaccine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Therapeutic Gene Engineered Subunit Vaccine
Table 3. Key Players of Preventative Gene Engineered Subunit Vaccine
Table 4. Global Gene Engineered Subunit Vaccine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Gene Engineered Subunit Vaccine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Gene Engineered Subunit Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Gene Engineered Subunit Vaccine Market Share by Region (2017-2022)
Table 8. Global Gene Engineered Subunit Vaccine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Gene Engineered Subunit Vaccine Market Share by Region (2023-2028)
Table 10. Gene Engineered Subunit Vaccine Market Trends
Table 11. Gene Engineered Subunit Vaccine Market Drivers
Table 12. Gene Engineered Subunit Vaccine Market Challenges
Table 13. Gene Engineered Subunit Vaccine Market Restraints
Table 14. Global Gene Engineered Subunit Vaccine Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Gene Engineered Subunit Vaccine Revenue Share by Players (2017-2022)
Table 16. Global Top Gene Engineered Subunit Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Engineered Subunit Vaccine as of 2021)
Table 17. Ranking of Global Top Gene Engineered Subunit Vaccine Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Gene Engineered Subunit Vaccine Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Engineered Subunit Vaccine Product Solution and Service
Table 21. Date of Enter into Gene Engineered Subunit Vaccine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Engineered Subunit Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2017-2022)
Table 25. Global Gene Engineered Subunit Vaccine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2023-2028)
Table 27. Global Gene Engineered Subunit Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Gene Engineered Subunit Vaccine Revenue Share by Application (2017-2022)
Table 29. Global Gene Engineered Subunit Vaccine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Gene Engineered Subunit Vaccine Revenue Share by Application (2023-2028)
Table 31. North America Gene Engineered Subunit Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Gene Engineered Subunit Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Gene Engineered Subunit Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Gene Engineered Subunit Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Gene Engineered Subunit Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Gene Engineered Subunit Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Gene Engineered Subunit Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Gene Engineered Subunit Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Gene Engineered Subunit Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Gene Engineered Subunit Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Gene Engineered Subunit Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Gene Engineered Subunit Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Gene Engineered Subunit Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Gene Engineered Subunit Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Gene Engineered Subunit Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Gene Engineered Subunit Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Gene Engineered Subunit Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Gene Engineered Subunit Vaccine Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Gene Engineered Subunit Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Gene Engineered Subunit Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Gene Engineered Subunit Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Gene Engineered Subunit Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Gene Engineered Subunit Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Gene Engineered Subunit Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Gene Engineered Subunit Vaccine Product
Table 64. Merck Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 65. Merck Recent Developments
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Gene Engineered Subunit Vaccine Product
Table 69. GSK Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 70. GSK Recent Developments
Table 71. Tiantan Company Details
Table 72. Tiantan Business Overview
Table 73. Tiantan Gene Engineered Subunit Vaccine Product
Table 74. Tiantan Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 75. Tiantan Recent Developments
Table 76. Pulike Company Details
Table 77. Pulike Business Overview
Table 78. Pulike Gene Engineered Subunit Vaccine Product
Table 79. Pulike Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 80. Pulike Recent Developments
Table 81. Greffex Company Details
Table 82. Greffex Business Overview
Table 83. Greffex Gene Engineered Subunit Vaccine Product
Table 84. Greffex Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 85. Greffex Recent Developments
Table 86. CureVac Company Details
Table 87. CureVac Business Overview
Table 88. CureVac Gene Engineered Subunit Vaccine Product
Table 89. CureVac Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 90. CureVac Recent Developments
Table 91. Yebio Company Details
Table 92. Yebio Business Overview
Table 93. Yebio Gene Engineered Subunit Vaccine Product
Table 94. Yebio Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 95. Yebio Recent Developments
Table 96. Sanofi Pasteur SA Company Details
Table 97. Sanofi Pasteur SA Business Overview
Table 98. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product
Table 99. Sanofi Pasteur SA Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 100. Sanofi Pasteur SA Recent Developments
Table 101. Virbac Company Details
Table 102. Virbac Business Overview
Table 103. Virbac Gene Engineered Subunit Vaccine Product
Table 104. Virbac Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 105. Virbac Recent Developments
Table 106. Pfizer Inc. Company Details
Table 107. Pfizer Inc. Business Overview
Table 108. Pfizer Inc. Gene Engineered Subunit Vaccine Product
Table 109. Pfizer Inc. Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 110. Pfizer Inc. Recent Developments
Table 111. Walvax Biotechnology Company Details
Table 112. Walvax Biotechnology Business Overview
Table 113. Walvax Biotechnology Gene Engineered Subunit Vaccine Product
Table 114. Walvax Biotechnology Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 115. Walvax Biotechnology Recent Developments
Table 116. Kontec Company Details
Table 117. Kontec Business Overview
Table 118. Kontec Gene Engineered Subunit Vaccine Product
Table 119. Kontec Revenue in Gene Engineered Subunit Vaccine Business (2017-2022) & (US$ Million)
Table 120. Kontec Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Engineered Subunit Vaccine Market Share by Type: 2021 VS 2028
Figure 2. Therapeutic Gene Engineered Subunit Vaccine Features
Figure 3. Preventative Gene Engineered Subunit Vaccine Features
Figure 4. Global Gene Engineered Subunit Vaccine Market Share by Application: 2021 VS 2028
Figure 5. Human Use Case Studies
Figure 6. Veterinary Use Case Studies
Figure 7. Gene Engineered Subunit Vaccine Report Years Considered
Figure 8. Global Gene Engineered Subunit Vaccine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Gene Engineered Subunit Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Gene Engineered Subunit Vaccine Market Share by Region: 2021 VS 2028
Figure 11. Global Gene Engineered Subunit Vaccine Market Share by Players in 2021
Figure 12. Global Top Gene Engineered Subunit Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Engineered Subunit Vaccine as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Gene Engineered Subunit Vaccine Revenue in 2021
Figure 14. North America Gene Engineered Subunit Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Gene Engineered Subunit Vaccine Market Size Market Share by Type (2017-2028)
Figure 16. North America Gene Engineered Subunit Vaccine Market Size Market Share by Application (2017-2028)
Figure 17. North America Gene Engineered Subunit Vaccine Market Size Share by Country (2017-2028)
Figure 18. United States Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Gene Engineered Subunit Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Type (2017-2028)
Figure 22. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Application (2017-2028)
Figure 23. Europe Gene Engineered Subunit Vaccine Market Size Share by Country (2017-2028)
Figure 24. Germany Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Gene Engineered Subunit Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Gene Engineered Subunit Vaccine Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Gene Engineered Subunit Vaccine Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Gene Engineered Subunit Vaccine Market Size Share by Region (2017-2028)
Figure 34. China Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Gene Engineered Subunit Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Gene Engineered Subunit Vaccine Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Gene Engineered Subunit Vaccine Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Gene Engineered Subunit Vaccine Market Size Share by Country (2017-2028)
Figure 44. Mexico Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Gene Engineered Subunit Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Gene Engineered Subunit Vaccine Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Gene Engineered Subunit Vaccine Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Gene Engineered Subunit Vaccine Market Size Share by Country (2017-2028)
Figure 50. Turkey Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Gene Engineered Subunit Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Merck Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 54. GSK Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 55. Tiantan Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 56. Pulike Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 57. Greffex Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 58. CureVac Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 59. Yebio Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 60. Sanofi Pasteur SA Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 61. Virbac Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 62. Pfizer Inc. Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 63. Walvax Biotechnology Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 64. Kontec Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Industry Market Size
